Skip to main content
HR 290 108th Congress House

Inflammatory Bowel Disease Act

Official title: To expand research regarding inflammatory bowel disease, and for other purposes.

Introduced: February 25, 2003 See on congress.gov
Health Agriculture and FoodAmbulatory careAnimalsClinical trials
More subjectsShow fewer subjects
CongressCongressional investigationsCongressional reporting requirementsDepartment of Health and Human ServicesDigestive diseasesDrug therapyEconomics and Public FinanceEducationEnvironmental ProtectionEnvironmentally induced diseasesEpidemiologyFederal aid to researchGenetic researchGeneticsGovernment Operations and Politics
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 3, 2003
Referred to the Subcommittee on Health.
Jan 8, 2003
Referred to the House Committee on Energy and Commerce.
Jan 8, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 3, 2003

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.

Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.

Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.

Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 290: Inflammatory Bowel Disease Act. 108th Congress. Open America. https://openamerica.io/bill/108-HR-290/
MLA
"H.R. 290: Inflammatory Bowel Disease Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-290/.
Bluebook (legal)
H.R. 290, 108th Cong. (2026), https://openamerica.io/bill/108-HR-290/.
Markdown link
[H.R. 290: Inflammatory Bowel Disease Act](https://openamerica.io/bill/108-HR-290/)
Report a problem